ARCHIVES

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

NCAB Approves Bypass Budget f $1.685 Billion for FY ’88, $200 Million More Than Asked For ‘87

May 30, 1986

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

More Oncopathology Research Asked

June 30, 1978

Administration Seeks Increase In FDA Budget.

June 13, 2008

NIH Chemical Genomics Center to screen small molecules.

June 18, 2004

New CCOP RFA To Encourage Cancer Control Research; Larger But Fewer Awards Are Likely

May 9, 1986